An extensive body of evidence highlighting the role of STAT3 in mediating resistance to (chemo-) radiotherapy first originated from analyses of head and neck squamous cell carcinomas (HNSCC). This evidence concerns the gene STAT3 and head and neck squamous cell carcinoma.